The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

By Ronald C. Kessler, P. Berglund, Olga V Demler, R. Jin, D. Koretz, Kathleen R. Merikangas, A. Rush, E. Walters, Philip S. Wang. Journal of the American Medical Association (JAMA), 2003

8,333 citations recorded by the source corpus.

Subfields: Applied Psychology, Pharmacology, Social Psychology

View Paper: https://www.semanticscholar.org/paper/00e33f7f39e3d77adb2de4716c4f784967676759

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Applied Psychology

1. Peter M. Gollwitzer
2. P. Sheeran
3. Thomas Llewelyn Webb
4. Brandon H Hidaka
5. G. Oettingen
6. E. Miles
7. Inge Schweiger Gallo
8. M. de Choudhury

In Pharmacology

1. B. Löwe
2. K. Kroenke
3. R. Spitzer
4. Janet B W Williams
5. Brandon H Hidaka
6. K. Gräfe
7. S. Gilbody
8. D. Schellberg

In Social Psychology

1. Ronald C. Kessler
2. Peter M. Gollwitzer
3. B. Löwe
4. K. Kroenke
5. Janet B W Williams
6. R. Spitzer
7. P. Sheeran
8. Philip S. Wang

Citations in the corpus

• Social functioning in major depressive disorder. (2016, neutral): “However, the US National Comorbidity Survey reported that, in the US, the social role impairment associated with depression was greater in the social role domain (43.4% severe or very severe) than in the work role domain (28.1% severe or very severe) (Kessler et al., 2003).”
• Brain volume abnormalities in major depressive disorder: A meta‐analysis of magnetic resonance imaging studies (2009, background): “With an estimated life-time risk of at least 10% [Kessler et al., 2003; Weissman et al., 1996] major depressive disorder (MDD) is one of the most common psychiatric illnesses.”
• The PHQ-8 as a measure of current depression in the general population. (2009, methodology): “The prevalence and impact of depression in the United States has been assessed in important populationbased studies, with modern methods first used in the EpidemiologicalCatchmentAreastudyintheearly1980s (RobinsandRegier,1991) and proceedingtotheNational Comorbidity Survey in 1990–1992 (Kessler et a”
• Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. (2007, background): “The correlates of major depression found in this study are similar to those reported in previous studies [28,41,42], suggesting that the factors that influence the likelihood of depression in chronically ill patients are probably no different from those that affect individuals without chronic medica”
• Reconsidering Anhedonia in Depression: Lessons from Translational Neuroscience (2010, background): “With a lifetime prevalence of approximately 16% (Kessler et al., 2003), Major Depressive Disorder (MDD) is predicted to become the second leading cause of death and disability in the United States by the year 2020 (Murray and Lopez, 1997).”
• Dysfunctional Attitudes and Early Maladaptive Schemas as Predictors of Depression: A 9-Year Follow-Up Study (2010, background): “…the occurrence of an episode of Major Depression (MD) has, indeed, been conceptualized as a potential serious and entrenched disorder due to its highly recurrent and for a substantial number of individuals, chronic course (Andrade et al. 2003; Judd 1997; Kessler et al. 2003; Solomon et al. 2000).”